Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Sunday, June 4, 2023.
SAB Biotherapeutics, Inc. (NASDAQ:SABS)
Bull Market Weakness (+75) - SABS is showing signs of short-term weakness, but still remains in the confines of a long-term uptrend. Keep an eye on SABS as it may be in the beginning stages of a reversal.
Is it time to buy, sell, or avoid SABS?
MarketClub looks at technical strength and momentum to determine if the timing is right for SABS.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for SABS
The long-term trend has been UP since Apr 18th, 2023 at 0.85
The intermediate-term trend has been UP since Apr 13th, 2023 at 0.60
The short-term trend has been UP since May 31st, 2023 at 0.91
Smart Scan Analysis for SABS
Based on our trend formula, SABS is rated as a +70 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 0.91 | 0.92 | 0.88 | 0.89 | -0.02 |
| Prev. Close | Volume | Bid | Ask | Time |
| 0.92 | 33992 | 2023-06-02 15:58:32 |
| 52wk High | 2.19 | 52wk High Date | 2022-06-03 |
| 52wk Low | 0.3657 | 52wk Low Date | 2023-04-10 |
| Average Volume | 595,974 | Shares Outstanding | 50,398 |
| Assets | 50,904,927M | Liabilities | 19,846,785M |